SumFlex 2025, hosted by NutrifyToday in Mumbai, has positioned India as a serious contender in the global nutraceutical market, with an ambitious vision of reaching USD 100 billion by 2047. With delegates from the U.S., South Korea, Malaysia, and beyond, the summit delivered on its promise to move the conversation from “factory to force”—establishing India as a hub of innovation, science, and regulatory integrity.
Amit Srivastava, Founder of NutrifyToday, called the event a “declaration of intent”, aligning cross-sector leaders around India’s wellness economy. He emphasized the shift from back-end manufacturing to global thought leadership in nutrition science.
Key announcements included:
-
A MoU between India Chambers and the Rural Economic Forum, enabling micro-enterprises and rural innovators to plug into global value chains.
-
The launch of Dealsphere.NutrifyToday.com, a first-of-its-kind digital platform enabling nutraceutical product commercialization within 15 days.
-
Debut of Celevida Diafiber by Dr. Reddy’s and Nestlé Health Science for metabolic wellness.
-
Launch of Rx.NutrifyToday.com, the world’s first digital reference tool for verifying nutraceutical claims and ingredients, set to evolve into a doctor-exclusive portal by October 2025.
Industry leaders including Cipla Health, Zydus, Torrent Pharma, Nestlé, Omniactive, BiogenExtracts, and global investors engaged in strategic panels on M&As, regulatory innovation, and AI-enabled product pipelines.
With a USD 18 billion current valuation and a 13.5% CAGR, India’s trajectory is mirroring the U.S. nutraceutical breakout of the early 2000s. As Dr. Anand Swaroop (Cepham USA) noted, India is poised to become the epicenter of science-led global nutrition.
SumFlex’s C-Suite focus delivered RoI-driven interactions over vanity optics, setting a new standard for business summits.
